Unknown

Dataset Information

0

Gene therapy for spinal muscular atrophy: the benefit-cost profile.

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC8343260 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Gene therapy for spinal muscular atrophy: the Qatari experience.
| S-EPMC8599021 | biostudies-literature
Unknown Spinal muscular atrophy.
| S-EPMC4514700 | biostudies-other
Unknown Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
| S-EPMC8548432 | biostudies-literature
Unknown miRNA in spinal muscular atrophy pathogenesis and therapy.
| S-EPMC5783860 | biostudies-literature
Unknown Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.
| S-EPMC5725447 | biostudies-literature
Unknown European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy.
| S-EPMC7347351 | biostudies-literature
Unknown The spinal and cerebral profile of adult spinal-muscular atrophy: A multimodal imaging study.
| S-EPMC6413472 | biostudies-literature
Unknown Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy.
| S-EPMC6590370 | biostudies-literature
Unknown Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders.
| S-EPMC8725368 | biostudies-literature
Unknown Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy.
| S-EPMC7686158 | biostudies-literature